Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ian, Bilmon"'
Autor:
Pietro R. Di Ciaccio, Georgia Mills, Michael J. Shipton, Belinda Campbell, Gareth Gregory, Jenna Langfield, Matthew Greenwood, Sean McKeague, Mohammad Shanavas, Renee Eslick, Giselle Kidson‐Gerber, Portia Smallbone, Catherine Tang, Kirk Morris, Ian Bilmon, Costas K. Yannakou, Xavier Badoux, Leanne Berkahn, Sergio Farina, Kylie D. Mason, Penelope Motum, Kathryn Goss, Nada Hamad
Publikováno v:
British Journal of Haematology. 201:887-896
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22ff1b3459c5cf904155769c8c265813
https://doi.org/10.1111/bjh.18727
https://doi.org/10.1111/bjh.18727
Autor:
Gaurav Sutrave, Adam Maundrell, Caitlin Keighley, Zoe Jennings, Susan Brammah, Min-Xia Wang, Roger Pamphlett, Cameron E. Webb, Damien Stark, Helen Englert, David Gottlieb, Ian Bilmon, Matthew R. Watts
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 8, Pp 1528-1531 (2018)
We describe the successful management of Anncaliia algerae microsporidial myositis in a man with graft versus host disease after hemopoietic stem cell transplantation. We also summarize clinical presentation and management approaches and discuss the
Externí odkaz:
https://doaj.org/article/a89290c841544952a5a3d4e521091a05
Autor:
Georgia S. Mills, Pietro R. Di Ciaccio, Catherine Tang, Verity Chadwick, Kylie D. Mason, Belinda A. Campbell, Michael J. Shipton, Mohamed Shanavas, Kirk L. Morris, Matthew Greenwood, Jenna Langfield, Giselle Kidson-Gerber, Renee Eslick, Xavier Badoux, Costas K. Yannakou, Shane A. Gangatharan, Ian Bilmon, Nada Hamad
Publikováno v:
Leukemia & Lymphoma. 64:319-328
Lymphoma in pregnancy is a rare and challenging diagnosis that complicates ∼1:6000 pregnancies; posing a series of unique therapeutic, social, and ethical challenges to the patient, her family, and the medical professionals involved. These difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccec941a5aa147e9835edc2f72c7e2b
https://doi.org/10.1080/10428194.2022.2148376
https://doi.org/10.1080/10428194.2022.2148376
Autor:
Richard Blennerhassett, Jad Othman, Amber Biscoe, David Kliman, Georgia Mills, Emily Blyth, Kenneth Micklethwaite, John Kwan, Ian Bilmon, Abir Bhattacharyya, Shyam Panicker, Keith Fay, Sam Milliken, David Ma, Nada Hamad, William Stevenson, Chris Arthur, John Moore, Matthew Greenwood, David Gottlieb, Ian Kerridge
Publikováno v:
Internal Medicine Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aa9c48e3c3d0d555c196c483b7f86aa
https://doi.org/10.1111/imj.16043
https://doi.org/10.1111/imj.16043
Autor:
Megan Hogg, Jacinta Perram, Abir Bhattacharyya, Ian Bilmon, Emily Blyth, John Kwan, Kenneth P. Micklethwaite, Shyam Panicker, Amanda Seabrook, David J Gottlieb
Publikováno v:
Blood. 140:7680-7681
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e07f9ddd2178f8e406379243c6b43e7c
https://doi.org/10.1182/blood-2022-159843
https://doi.org/10.1182/blood-2022-159843
Autor:
Bartlomiej Getta, Emily Blyth, Vicki Antonenas, Megan Hogg, Ian Bilmon, Shyam Panicker, Abir Bhattacharyya, John Kwan, David Collins, Stephanie Deren, Gillian Huang, David Gottlieb, Daochen Tong, Kenneth P. Micklethwaite
Publikováno v:
Internal Medicine Journal. 50:299-306
BACKGROUND Donor safety is paramount when performing bone marrow stem cell harvest. The incidence of full blood count (FBC) abnormalities among donors and variables associated with anaemia after marrow harvest are not well established. AIMS To descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f37fe4add34bce20d31754425dcb566
https://doi.org/10.1111/imj.14419
https://doi.org/10.1111/imj.14419
Autor:
Michael Murray, Devendra K Hiwase, Glen A Kennedy, Nichloas Murphy, Stephen B. Ting, Ashish Bajel, Paula Marlton, Ing Soo Tiong, Harry J. Iland, Simon He, Mark J. Levis, Sam Yuen, Andrew W. Roberts, Joanna Leadbetter, Campbell Tiley, Natasha S Anstee, Meaghan Wall, Tristan Rawling, Gavin Cull, Kirk Morris, Andrew Grigg, Uyen Nguyen, Maya Latimer, Doen Ming Ong, Sundra Ravanathan, John Taper, Anthony P. Schwarer, Uwe Hahn, James D'Rozario, Ian Bilmon, Andrew H. Wei, Sun Loo, Anoop K Enjeti, Emma Verner
Publikováno v:
Blood. 136:36-38
Introduction Midostaurin is the only approved FLT3 inhibitor for combination with intensive induction and consolidation chemotherapy in newly diagnosed patients with FLT3 mutant AML. The FLT3 inhibitor, sorafenib, was investigated in the randomized S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8c176d1c84db3e7f79c3eaa23097bff
https://doi.org/10.1182/blood-2020-137334
https://doi.org/10.1182/blood-2020-137334
Autor:
Michael Murray, Paula Marlton, Andrew Grigg, Andrew W. Roberts, Sarah MacRaild, Tristan Rawling, James D'Rozario, Giovanna Pomilio, Adam Ivey, Anthony P. Schwarer, Glen A Kennedy, Mark J. Levis, Doen Ming Ong, Anoop K Enjeti, Ian Bilmon, Andrew H. Wei, Natasha S Anstee
Publikováno v:
Blood. 136:16-18
Introduction The Australasian Leukaemia and Lymphoma Group (ALLG) conducted a randomized trial (AMLM16) combining the FLT3 inhibitor sorafenib (SOR) or placebo (PBO) with intensive induction and consolidation chemotherapy, followed by 12 months of ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1f1c0b3c02f16f7a7604ffbf0b90edf
https://doi.org/10.1182/blood-2020-141711
https://doi.org/10.1182/blood-2020-141711
Autor:
Christopher Arthur, Sam Milliken, Ian Bilmon, David Gottlieb, Matthew Greenwood, Shyam Panicker, Jad Othman, David D.F. Ma, Keith Fay, Leonie Wilcox, John Kwan, Emily Blyth, William Stevenson, John Moore, Nada Hamad, Lindsay Dunlop, Stephen Larsen, Ian Kerridge, Adam Bryant, Kenneth P. Micklethwaite, Anne-Marie Watson, Abir Bhattacharyya, Barbara Withers, Steven Tran, John Gibson, Christian E Bryant
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 26(10)
Recipients of allogeneic hematopoietic stem cell transplantation (HSCT) from unrelated donors (URDs) and mismatched related donors (MMRDs) typically have a higher incidence of acute and chronic graft-versus-host disease (GVHD) compared with matched r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9b5ed0f8be9d5d5c26ae34fca767ee
https://pubmed.ncbi.nlm.nih.gov/32640314
https://pubmed.ncbi.nlm.nih.gov/32640314
Autor:
Shyam Panicker, Emily Blyth, Gillian Huang, David Gottlieb, Kenneth P. Micklethwaite, David Kliman, John Kwan, Vicki Antonenas, Ian Bilmon, Stephanie Deren, Abir Bhattacharyya
Publikováno v:
Internal Medicine Journal. 48:988-991
Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant-related mortality from infection and graft-versus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d7589dc44237d9f5456291b1e9f740e
https://doi.org/10.1111/imj.13979
https://doi.org/10.1111/imj.13979